Ancillary hospital location includes those support locations other than board, room, medical and nursing services that are offered to the patients during their course of care. These locations include radiology, laboratory, physical therapy services, emergency rooms, operation rooms and intensive care units (ICUs). Diagnostic testing at these critical care centers must be accurate and immediate so as to deliver the accurate treatment for the disease condition. Ancillary hospital locations diagnostic testing is majorly used and is very essential for confirming the recovery status of the patients and their results are considered strongly for approving the discharge from emergency or ICU rooms.
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1809
On the basis of the types of diagnostic testing, ancillary locations diagnostic testing market has been segmented as follows:
-Infectious disease testing
-Routine hematology analysis
-Radiology testing
-Routine urine analysis
-Hypersensitivity testing
-Drug of abuse testing
Infectious disease testing dominates the ancillary hospital location diagnostic testing market majorly due to high prevalence rate of the infectious diseases and maximum ICUs stays by the patients suffering from infectious diseases. According to World Health Organization (WHO), 35.3 million people were suffering from HIV or AIDS worldwide in 2012 and statistics record that 1.6 million people died globally due to AIDS related illness in 2012. WHO reports also stated that tuberculosis (TB) is second to AIDS as the furthermost killer worldwide caused due to single infectious agent.
In 2012, 8.6 million people were diagnosed with TB worldwide, among which 1.3 million people died. High prevalence rate of infectious diseases and the mortality rate associated with it leads to excess hospital admissions and increased ancillary hospital location diagnostic testing. Radiology market however, is estimated as the fastest growing market owing to its excessive use in diagnosis of various disease conditions including cardiovascular, neural and nervous system disorders. Radiology market is further differentiated into the types of radiology testing which includes:
-X-ray testing
-Electrocardiogram (ECG)
-Ultrasound
-Computed tomography scan (CT Scan)
-Magnetic resonance imaging (MRI)
-Others (radioactive imaging for cancer)
Increasing awareness about the diseases conditions and available diagnostic and treatment methods are leading to rise in per capital healthcare spending and number of hospitals especially in developing economies of Asia Pacific and Africa region, resulting in growth of ancillary hospital location diagnostic testing market. For instance, according to the Central Bureau of Health Intelligence, the number of government hospitals in India has increased from 4,571 in 2000 to 11,993 in 2011. Increasing number of hospitals coupled with the rising awareness and need for healthy lifestyle is propelling the demand for ancillary hospital diagnostic testing market.
Additionally, increased medical tourism from countries across North America and Europe towards the Asian and the Middle East countries for low cost treatment without compromising the quality is also increasing the demand for ancillary hospital location diagnostic testing in these nations, hence driving the market. According to the Medical Tourism in India, heart bypass surgery in India costs USD 5,200, while it costs USD 144,000 in the U.S. Low treatment cost is attracting patients toward emerging economies for treatment, which would drive the ancillary hospital location diagnostic testing market during the forecast period.
Some of the major market players of ancillary hospital location diagnostic testing market include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, EKF Diagnostics, Thermo Fisher Scientific Corporation, Lonza Group, Siemens Healthcare, Nihon Kohden Corporation, Takara Bio Inc. and F. Hoffmann-La Roche AG.
